Skip to content
Log in
Sponsored Artificial Intelligence: A Modern Approach, Global Edition Artificial Intelligence: A Modern Approach, Global Edition
Review

Phage and CRISPR based precision antimicrobials: a dual strategy against multidrug-resistant bacteria

Anjaneyulu Musini V. Yata Sarad Pawar Naik Bukke Kalal Akhila Teetla Shivani Bayapareddy Narapureddy Chandrashekar Thalluri Awad Osman Abdalla Mohamed Mohammed Dhawelbate Mohammed Adam
Aug 2026 · Molecular Biology Reports · Vol 53 · 0 citations · 68 references
Medicine

TL;DR

This review critically examines bacteriophage-based antimicrobials, CRISPR-Cas therapeutic systems, and their emerging integration as CRISPR-armed phages, highlighting their comparative advantages, current limitations, and future potential as promising targeted antimicrobial approach platforms requiring further clinical validation.

DOI PubMed Semantic Scholar
View source

Similar papers

Review Jul 2026

Artificial intelligence and CRISPR-based approaches for targeted delivery of bacteriophages.

A systematic overview of bacteriophage biology, life cycle, and mechanisms of action is provided, highlighting the influence of phage morphology on therapeutic performance, recent advances, current clinical and preclinical studies, and future perspectives.

Rika Rani Pradhan, Sanghamitra Pati, S. K. Samal · 0 citations
Review Aug 2026

CRISPR/Cas system as a novel therapeutic strategy to combat multi-drug-resistant bacteria

This study investigates the CRISPR-Cas framework’s potential as a cutting-edge tactic to fight antimicrobial resistance, and finds that the efficiency of CRISPR-Cas is diminished in some bacterial strains due to variations in their CRISPR loci.

Akmal Zubair, M. Hemal, Alaeldeen Ahmed et al. · 0 citations
Review Open access Aug 2026

Phage Therapy Enhanced by Using Engineered Bacteriophages: A Powerful Antibacterial Tool to Address the Dilemma Posed by Multidrug-Resistant Bacterial Infections

The increasing clinical evidence shows that synthetic biology can effectively overcome the inherent defects of natural bacteriophages, confirming the safety and initial efficacy of bacteriophage therapy.

Xuan Wang, Haolin Zhou, T. S. Lim et al. · 0 citations
Review Open access Jul 2026

CRISPR-ENABLED ANTIMICROBIAL STRATEGIES: REDEFINING PRECISION THERAPY AGAINST MULTIDRUG RESISTANT PATHOGENS

Overall, CRISPR-based antimicrobial therapy represents a transformative approach to precision infectious disease management, with continued technological innovation, interdisciplinary collaboration, and robust clinical validation expected to facilitate its safe, effective, and clinically accessible implementation again...

Dipankar Mukhopadhyay, Dr. Shilanjali Bhalerao, Dr. Vijayendra Gautam et al. · 0 citations
Review Aug 2026

Bacteriophage Therapy as a Promising Substitute for Antibiotics: Current Advances, Clinical Applications, and Future Perspectives

Accumulating experimental and clinical evidence indicates that bacteriophage therapy could become an important component of future antimicrobial strategies, and Continued multidisciplinary research, standardized clinical protocols, and well-designed randomized clinical trials are essential to establish its long-term ef...

Himadri Sharma · 0 citations
Open access Jul 2026

Plasmid-mediated multidrug resistance and the antibacterial potential of plant seed proteins

Chickpea proteins, especially the basic subunit (BS) fraction, demonstrated significant antibacterial activity against MDR pathogens, offering a promising natural alternative to conventional antibiotics.

Reham Sobhy, H. El-Beltagi, Othman M. Al-Dossary et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.